The engagement of brain cytochrome P450 in the metabolism of endogenous neuroactive substrates: a possible role in mental disorders

References

• Andreasen NC, Pierson R. 2008. The role of the cerebellum in schizophrenia. Biol Psychiatry. 6:81–88.
   Web of Science ®Google Scholar
• Arlotto MP, Trant JM, Estabrook RW. 1991. Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function. Meth Enzymol. 206:454–462.
   PubMed Web of Science ®Google Scholar
• Asai Y, Tanaka H, Nadai M, Katoh M. 2018. Status epilepticus decreases brain cytochrome P450 2D4 expression in rats. J Pharm Sci. 107:975–978.
   PubMed Web of Science ®Google Scholar
• Badawi AF, Cavalieri EL, Rogan EG. 2001. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metab Clin Exp. 50:1001–1003.
   PubMed Web of Science ®Google Scholar
• Belmaker RH, Agam G. 2008. Major depressive disorder. N Engl J Med. 358:55–68.
   PubMed Web of Science ®Google Scholar
• Berry MD. 2004. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem. 90:257–271.
   PubMed Web of Science ®Google Scholar
• Bertilsson L, Alm C, De Las Carreras C, Widen J, Edman G, Schalling D. 1989. Debrisoquine hydroxylation polymorphism and personality. Lancet. 1:555.
   PubMed Web of Science ®Google Scholar
• Bromek E, Haduch A, Daniel WA. 2010. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: an in vitro study. Eur J Pharmacol. 626:171–178.
   PubMed Web of Science ®Google Scholar
• Bromek E, Haduch A, Gołembiowska K, Daniel WA. 2011. Cytochrome P450 mediates dopamine formation in the brain in vivo. J Neurochem. 118:806–815.
   PubMed Web of Science ®Google Scholar
• Cacabelos R, Torellas C, López-Muñoz F. 2016. Pharmacogenomics of antidepressant drugs. In: López-Muñoz, Srinivasan V, de Berardis D, Álamo C, Kato TA, editors. Melatonin, neuroprotective agents and antidepressant therapy. India: Springer; p. 545–610.
   Google Scholar
• Caligiore D, Pezzulo G, Baldassarre G, Bostan AC, Strick PL, Doya K, Helmich RC, Dirkx M, Houk J, Jörntell H, et al. 2017. Consensus Paper: towards a systems-level view of cerebellar function: the interplay between cerebellum, basal ganglia, and cortex. Cerebellum. 16:203–229.
   PubMed Web of Science ®Google Scholar
• Chamniansawat S, Sawatdiyaphanon C. 2018. Age-related memory impairment associated with decreased endogenous estradiol in the hippocampus of female rats. Int J Toxicol. 37:207–215.
   PubMed Web of Science ®Google Scholar
• Cheng J, Zhen Y, Miksys S, Beyoğlu D, Krausz KW, Tyndale RF, Yu A, Idle JR, Gonzalez FJ. 2013. Potential role of CYP2D6 in the central nervous system. Xenobiotica. 43:973–984.
   PubMed Web of Science ®Google Scholar
• Chowdhuri DK, Parmar D, Kakkar P, Shukla R, Seth PK, Srimal RC. 2002. Antistress effects of bacosides of Bacopa monnieri: modulation of Hsp70 expression, superoxide dismutase and cytochrome P450 activity in rat brain. Phytother Res. 16:639–645.
   PubMed Web of Science ®Google Scholar
• Colciago A, Casati L, Negri-Cesi P, Celotti F. 2015. Learning and memory: steroids and epigenetics. J Steroid Biochem Mol Biol. 150:64–85.
   PubMed Web of Science ®Google Scholar
• Coppen A. 1967. The biochemistry of affective disorders. Br J Psychiatry. 113:1237–1264.
   PubMed Web of Science ®Google Scholar
• Ebdrup BH, Rasmussen H, Arnt J, Glenthøj B. 2011. Serotonin 2A receptor antagonists for treatment of schizophrenia. Expert Opin Investig Drugs. 20:1211–1223.
   PubMed Web of Science ®Google Scholar
• Dalack GW, Becks L, Hill E, Pomerleau OF, Meador-Woodruff JH. 1999. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia. Neuropsychopharmacology. 21:195–202.
   PubMed Web of Science ®Google Scholar
• Daskalopoulos EP, Malliou F, Rentesi G, Marselos M, Lang MA, Konstandi M. 2012. Stress is a critical player in CYP3A, CYP2C, and CYP2D regulation: role of adrenergic receptor signaling pathways. Am J Physiol Endocrinol Metab. 303:40–54.
   PubMed Web of Science ®Google Scholar
• Davis CM, Liu X, Alkayed NJ. 2017. Cytochrome P450 eicosanoids in cerebrovascular function and disease. Pharmacol Ther. 179:31–46.
   PubMed Web of Science ®Google Scholar
• Di Giovanni G, Di Matteo V, Pierucci M, Esposito E. 2008. Serotonin-dopamine interaction: electrophysiological evidence. Prog Brain Res. 172:45–71.
   PubMed Web of Science ®Google Scholar
• Djelti F, Braudeau J, Hudry E, Dhenain M, Varin J, Bièche I, Marquer C, Chali F, Ayciriex S, Auzeil N, et al. 2015. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease. Brain. 138:2383–2398.
   PubMed Web of Science ®Google Scholar
• Fradette C, Yamaguchi N, Du Souich P. 2004. 5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide. Br J Pharmacol. 141:407–414.
   PubMed Web of Science ®Google Scholar
• Garcia AN, Muniz MT, Souza e Silva HR, da Silva HA, Athayde-Junior L. 2009. Cyp46 polymorphisms in Alzheimer's disease: a review. J Mol Neurosci. 39:342–345.
   PubMed Web of Science ®Google Scholar
• Ghosh C, Hossain M, Solanki J, Dadas A, Marchi N, Janigro D. 2016. Pathophysiological implications of neurovascular P450 in brain disorders. Drug Discov Today. 21:1609–1619.
   PubMed Web of Science ®Google Scholar
• Ghosh C, Hossain M, Solanki J, Najm IM, Marchi N, Janigro D. 2017. Overexpression of pregnane X and glucocorticoid receptors and the regulation of cytochrome P450 in human epileptic brain endothelial cells. Epilepsia. 58:576–585.
   PubMed Web of Science ®Google Scholar
• Gjota-Ergin S, Gökçek-Saraç Ç, Adalı O, Jakubowska-Doğru E. 2018. Relationship between the hippocampal expression of selected cytochrome P450 isoforms and the animal performance in the hippocampus-dependent learning task. Neurosci Lett. 673:104–110.
   PubMed Web of Science ®Google Scholar
• Gokhale MS, Bunton TE, Zurlo J, Yager JD. 1997. Cytochrome P450 isoenzyme activities in cultured rat and mouse liver slices. Xenobiotica. 27:341–355.
   PubMed Web of Science ®Google Scholar
• Gonzáles I, Peñas-Lledo E, Pérez B, Dorado P, Alvarez M, Llerena A. 2008. Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers. Pharmacogenomics. 9:833–840.
   PubMed Web of Science ®Google Scholar
• Háber A, Rideg O, Osváth P, Fekete S, Szücs F, Fittler A, Kovács GL, Miseta A, Botz L. 2013. Patients with difficult-to-treat depression do not exhibit an increased frequency of CYP2D6 allele duplication. Pharmacopsychiatry. 46:156–160.
   PubMed Web of Science ®Google Scholar
• Haduch A, Bromek E, Daniel WA. 2013a. Role of brain cytochrome P450 (CYP2D) in the metabolism of monoaminergic neurotransmitters. Pharmacol Rep. 65:1519–1528.
   PubMed Web of Science ®Google Scholar
• Haduch A, Bromek E, Daniel WA. 2011. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain. Eur J Pharmacol. 651:51–58.
   PubMed Web of Science ®Google Scholar
• Haduch A, Bromek E, Kot M, Kamińska K, Gołembiowska K, Daniel WA. 2015. The cytochrome P450 2D-mediated formation of serotonin from 5-methoxytryptamine in the brain in vivo: a microdialysis study. J Neurochem. 133:83–92.
   PubMed Web of Science ®Google Scholar
• Haduch A, Bromek E, Sadakierska-Chudy A, Wójcikowski J, Daniel WA. 2013b. The catalytic competence of cytochrome P450 in the synthesis of serotonin from 5-methoxytryptamine in the brain: an in vitro study. Pharmacol Res. 67:53–59.
   PubMed Web of Science ®Google Scholar
• Haduch A, Bromek E, Wójcikowski J, Gołembiowska K, Daniel WA. 2016. Melatonin supports CYP2D-mediated serotonin synthesis in the brain. Drug Metab Dispos. 44:445–452.
   PubMed Web of Science ®Google Scholar
• Haduch A, Rysz M, Papp M, Daniel WA. 2018. The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat. Biochem Pharmacol. 156:398–405.
   PubMed Web of Science ®Google Scholar
• Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM. 2013. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biol Psychiatry. 74:436–443.
   PubMed Web of Science ®Google Scholar
• He XM, Zhang ZX, Zhang JW, Zhou YT, Wu CB, Tang MN, Hong Z. 2012. An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population. J Mol Neurosci. 47:514–518.
   PubMed Web of Science ®Google Scholar
• Hedlund E, Wyss A, Kainu T, Backlund M, Köhler C, Pelto-Huikko M, Gustafsson JA, Warner M. 1996. Cytochrome P4502D4 in the brain: specific neuronal regulation by clozapine and toluene. Mol Pharmacol. 50:342–350.
   PubMed Web of Science ®Google Scholar
• Hiroi T, Imaoka S, Funae Y. 1998. Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun. 249:838–843.
   PubMed Web of Science ®Google Scholar
• Hiroi T, Kishimoto W, Chow T, Imaoka S, Igarashi T, Funae Y. 2001. Progesterone oxidation by cytochrome P450 2D isoforms in the brain. Endocrinology. 142:3901–3908.
   PubMed Web of Science ®Google Scholar
• Iivonen S, Heikkinen T, Puoliväli J, Helisalmi S, Hiltunen M, Soininen H, Tanila H. 2006. Effects of estradiol on spatial learning, hippocampal cytochrome P450 19, and estrogen alpha and beta mRNA levels in ovariectomized female mice. Neuroscience. 137:1143–1152.
   PubMed Web of Science ®Google Scholar
• Ingelman-Sundberg M, Persson A, Jukic MM. 2014. Polymorphic expression of CYP2C19 and CYP2D6 in the developing and adult human brain causing variability in cognition, risk for depression and suicide: the search for the endogenous substrates. Pharmacogenomics. 15:1841–1844.
   PubMed Web of Science ®Google Scholar
• Jia F, Liu Z, Song N, Du X, Xie J, Jiang H. 2016. The association between CYP46A1 rs4900442 polymorphism and the risk of Alzheimer's disease: a meta-analysis. Neurosci Lett. 620:83–87.
   PubMed Web of Science ®Google Scholar
• Jukić MM, Opel N, Ström J, Carrillo-Roa T, Miksys S, Novalen M, Renblom A, Sim SC, Peñas-Lledó EM, Courtet P, et al. 2017. Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment. Mol Psychiatry. 22:1155–1163.
   PubMed Web of Science ®Google Scholar
• Khan AH, Zaidi S. 2017. Clozapine: improvement of negative symptoms of Schizophrenia. Cureus. 9:e1973. doi: 10.7759/cureus.1973.
   PubMed Web of Science ®Google Scholar
• Konstandi M. 2013. Psychophysiological stress: a significant parameter in drug pharmacokinetics. Expert Opin Drug Metab Toxicol. 9:1317–1334.
   PubMed Web of Science ®Google Scholar
• Kot M, Haduch A, Papp M, Daniel WA. 2017. The effect of chronic treatment with lurasidone on rat liver cytochrome P450 expression and activity in the chronic mild stress model of depression. Drug Metab Dispos. 45:1336–1344.
   PubMed Web of Science ®Google Scholar
• Liu M, Hurn PD, Alkayed NJ. 2004. Cytochrome P450 in neurological disease. Curr Drug Metab. 5:225–234.
   PubMed Web of Science ®Google Scholar
• Llerena A, Edman G, Cobaleda J, Benitez J, Schalling D, Bertilsson L. 1993. Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6. Acta Psychiatr Scand. 87:23–28.
   PubMed Web of Science ®Google Scholar
• Maioli S, Båvner A, Ali Z, Heverin M, Ismail MA, Puerta E, Olin M, Saeed A, Shafaati M, Parini P, et al. 2013. Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain? PLoS One. 8:e68534.
   PubMed Web of Science ®Google Scholar
• Mann A, Miksys S, Lee A, Mash DC, Tyndale RF. 2008. Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment. Neuropharmacology. 55:1147–1155.
   PubMed Web of Science ®Google Scholar
• McMillan DM, Tyndale RF. 2018. CYP-mediated drug metabolism in the brain impacts drug response. Pharmacol Ther. 184:189–200.
   PubMed Web of Science ®Google Scholar
• Melcangi RC, Garcia-Segura LM, Mensah-Nyagan AG. 2008. Neuroactive steroids: state of the art and new perspectives. Cell Mol Life Sci. 65:777–797.
   PubMed Web of Science ®Google Scholar
• Meltzer HY. 2013. Update on typical and atypical antipsychotic drugs. Annu Rev Med. 64:393–406.
   PubMed Web of Science ®Google Scholar
• Michaud J, Naud J, Chouinard J, Désy F, Leblond FA, Desbiens K, Bonnardeaux A, Pichette V. 2006. Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure. J Am Soc Nephrol. 17:3041–3048.
   PubMed Web of Science ®Google Scholar
• Miksys S, Rao Y, Hoffmann E, Mash DC, Tyndale RF. 2002. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J Neurochem. 82:1376–1387.
   PubMed Web of Science ®Google Scholar
• Miksys S, Rao Y, Sellers EM, Kwan M, Mendis D, Tyndale RF. 2000. Regional and cellular distribution of CYP2D subfamily members in rat brain. Xenobiotica. 30:547–564.
   PubMed Web of Science ®Google Scholar
• Miksys S, Tyndale RF. 2013. Cytochrome P450-mediated drug metabolism in the brain. J Psychiatry Neurosci. 38:152–163.
   PubMed Web of Science ®Google Scholar
• Miksys S, Tyndale RF. 2004. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics. Drug Metab Rev. 36:313–333.
   PubMed Web of Science ®Google Scholar
• Miller RT, Miksys S, Hoffmann E, Tyndale RF. 2014. Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys. Br J Pharmacol. 171:3077–3038.
   PubMed Web of Science ®Google Scholar
• Murakami G, Tanabe N, Ishii HT, Ogiue-Ikeda M, Tsurugizawa T, Mukai H, Hojo Y, Takata N, Furukawa A, Kimoto T, et al. 2006. Role of cytochrome p450 in synaptocrinology: endogenous estrogen synthesis in the brain hippocampus. Drug Metab Rev. 38:353–369.
   PubMed Web of Science ®Google Scholar
• Napolitano G, Stingl JC, Schmid M, Viviani R. 2017. Predicting CYP2D6 phenotype from resting brain perfusion images by gradient boosting. Psychiatry Res Neuroimaging. 259:16–24.
   PubMed Web of Science ®Google Scholar
• Navarro-Mabarak C, Camacho-Carranza R, Espinosa-Aguirre JJ. 2018. Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases. Drug Metab Rev. 50:95–108.
   PubMed Web of Science ®Google Scholar
• Naud J, Harding J, Lamarche C, Beauchemin S, Leblond FA, Pichette V. 2016. Effects of chronic renal failure on brain cytochrome P450 in rats. Drug Metab Dispos. 44:1174–1179.
   PubMed Web of Science ®Google Scholar
• Nelson DR. 2011. Progress in tracing the evolutionary paths of cytochrome P450. Biochim Biophys Acta. 1814:14–18.
   PubMed Web of Science ®Google Scholar
• Nishimura M, Naito S, Yokoi T. 2004. Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies. Drug Metab Pharmacokinet. 19:135–149.
   PubMedGoogle Scholar
• Omura T, Sato R. 1964. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem. 239:2370–2378.
   PubMed Web of Science ®Google Scholar
• Peñas-Lledó E, Guillaume S, Naranjo ME, Delgado A, Jaussent I, Blasco-Fontecilla H, Courtet P, LLerena A. 2015. A combined high CYP2D6–CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances. Pharmacogenomics J. 15:172–176.
   PubMed Web of Science ®Google Scholar
• Peñas-Lledó EM, Llerena A. 2014. CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials. Br J Clin Pharmacol. 77:673–683.
   PubMed Web of Science ®Google Scholar
• Persson A, Sim SC, Virding S, Onishchenko N, Schulte G, Ingelman-Sundberg M. 2014. Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene. Mol Psychiatry. 19:733–741.
   PubMed Web of Science ®Google Scholar
• Petersen SL, Curran MA, Marconi SA, Carpenter CD, Lubbers LS, McAbee MD. 2000. Distribution of mRNAs encoding the arylhydrocarbon receptor, arylhydrocarbon receptor nuclear translocator, and arylhydrocarbon receptor nuclear translocator-2 in the rat brain and brainstem. J Comp Neurol. 427:428–439.
   PubMed Web of Science ®Google Scholar
• Pinna G, Costa E, Guidotti A. 2006. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl). 186:362–372.
   PubMed Web of Science ®Google Scholar
• Potvin S, Lungu O, Lipp O, Lalonde P, Zaharieva V, Stip E, Melun JP, Mendrek A. 2016. Increased ventro-medial prefrontal activations in schizophrenia smokers during cigarette cravings. Schizophr Res. 173:30–36.
   PubMed Web of Science ®Google Scholar
• Qi XR, Luchetti S, Verwer RWH, Sluiter AA, Mason MRJ, Zhou JN, Swaab DF. 2018. Alterations in the steroid biosynthetic pathways in the human prefrontal cortex in mood disorders: a post-mortem study. Brain Pathol. 28:536–547.
   PubMed Web of Science ®Google Scholar
• Rasmusson AM, Pinna G, Paliwal P, Weisman D, Gottschalk C, Charney D, Krystal J, Guidotti A. 2006. Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol Psychiatry. 60:704–713.
   PubMed Web of Science ®Google Scholar
• Romeo E, Ströhle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R. 1998. Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry. 155:910–913.
   PubMed Web of Science ®Google Scholar
• Runtz L, Girard B, Toussenot M, Espallergues J, Fayd'Herbe De Maudave A, Milman A, deBock F, Ghosh C, Guérineau NC, Pascussi JM, et al. 2018. Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures. Epilepsia. 59:123–134.
   PubMed Web of Science ®Google Scholar
• Ryan DE, Levin W. 1990. Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol Ther. 45:153–239.
   PubMed Web of Science ®Google Scholar
• Samardzic J, Hencic B, Jancic J, Jadzic D, Djuric M, Obradovic DI, Svob Strac D. 2017. Neurosteroid dehydroepiandrosterone improves active avoidance retrieval and induces antidepressant-like behavior in rats. Neurosci Lett. 660:17–21.
   PubMed Web of Science ®Google Scholar
• Sasame HA, Ames MM, Nelson SD. 1977. Cytochrome P-450 and NADPH cytochrome c reductase in rat brain: formation of catechols and reactive catechol metabolites. Biochem Biophys Res Commun. 78:919–926.
   PubMed Web of Science ®Google Scholar
• Schmahmann JD. 2004. Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci. 16:367–378.
   PubMed Web of Science ®Google Scholar
• Schildkraut JJ. 1965. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 122:509–522.
   PubMed Web of Science ®Google Scholar
• Schutter DJ. 2016. A cerebellar framework for predictive coding and homeostatic regulation in depressive disorder. Cerebellum. 15:30–33.
   PubMed Web of Science ®Google Scholar
• Schüle C, Nothdurfter C, Rupprecht R. 2014. The role of allopregnanolone in depression and anxiety. Prog Neurobiol. 113:79–87.
   PubMed Web of Science ®Google Scholar
• Sim SC, Nordin L, Andersson TM, Virding S, Olsson M, Pedersen NL, Ingelman-Sundberg M. 2010. Association between CYP2C19 polymorphism and depressive symptoms. Am J Med Genet B Neuropsychiatr Genet. 153:1160–1166.
   Web of Science ®Google Scholar
• Stahl SM. 2013. Stahl’s essential psychopharmacology: neuroscientific basis and practical applications. In Psychosis and schozophrenia. 4th ed. Cambridge (UK): Cambridge University Press; Chapter 4. p. 86–114.
   Google Scholar
• Stingl JC. 2018. Mindful pharmacogenetics: drug dosing for mental health. Am J Psychiatry. 175:395–397.
   PubMed Web of Science ®Google Scholar
• Stingl JC, Brockmöller J, Viviani R. 2012a. Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function. Mol Psychiatry. 18:273–287.
   PubMed Web of Science ®Google Scholar
• Stingl JC, Esslinger C, Tost H, Bilek E, Kirsch P, Ohmle B, Viviani R, Walter H, Rietschel M, Meyer-Lindenberg A. 2012b. Genetic variation in CYP2D6 impacts neural activation during cognitive tasks in humans. Neuroimage. 59:2818–2823.
   PubMed Web of Science ®Google Scholar
• Stoffel-Wagner B. 2001. Neurosteroid metabolism in the human brain. Eur J Endocrinol. 145:669–679.
   PubMed Web of Science ®Google Scholar
• Ströhle A, Pasini A, Romeo E, Hermann B, Spalletta G, di Michele F, Holsboer F, Rupprecht R. 2000. Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression. J Psychiatr Res. 34:183–186.
   PubMed Web of Science ®Google Scholar
• Ströhle A, Romeo E, Hermann B, Pasini A, Spalletta G, di Michele F, Holsboer F, Rupprecht R. 1999. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol Psychiatry. 45:274–277.
   PubMed Web of Science ®Google Scholar
• Thanacoody RH. 2011. Thioridazine: the good and the bad. Recent Pat Antiinfect Drug Discov. 6:92–98.
   PubMedGoogle Scholar
• Tobiansky DJ, Korol AM, Ma C, Hamden JE, Jalabert C, Tomm RJ, Soma KK. 2018a. Testosterone and corticosterone in the mesocorticolimbic system of male rats: effects of gonadectomy and caloric restriction. Endocrinology. 159:450–464.
   PubMed Web of Science ®Google Scholar
• Tobiansky DJ, Wallin-Miller KG, Floresco SB, Wood RI, Soma KK. 2018b. Androgen regulation of the mesocorticolimbic system and executive function. Front Endocrinol (Lausanne). 9:279.
   PubMed Web of Science ®Google Scholar
• Toselli F, Dodd PR, Gillam EM. 2016. Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs. Drug Metab Rev. 48:379–404.
   PubMed Web of Science ®Google Scholar
• Turman CM, Hatley JM, Ryder DJ, Ravindranath V, Strobel HW. 2006. Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: the convolution continues. Expert Opin Drug Metab Toxicol. 2:399–418.
   PubMed Web of Science ®Google Scholar
• Tyndale RF, Li Y, Li NY, Messina E, Miksys S, Sellers EM. 1999. Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan. Drug Metab Dispos. 27:924–930.
   PubMed Web of Science ®Google Scholar
• Uzunov DP, Cooper TB, Costa E, Guidotti A. 1996. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci U S A. 93:12599–12604.
   PubMed Web of Science ®Google Scholar
• Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A. 1998. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA. 95:3239–3324.
   PubMed Web of Science ®Google Scholar
• Verbeek MM, Geurtz PB, Willemsen MA, Wevers RA. 2007. Aromatic L-amino acid decarboxylase enzyme activity in deficient patients and heterozygotes. Mol Genet Metab. 90:363–369.
   PubMed Web of Science ®Google Scholar
• Wang X, Li J, Dong G, Yue J. 2014. The endogenous substrates of brain CYP2D. Eur J Pharmacol. 724:211–218.
   PubMed Web of Science ®Google Scholar
• Wang HL, Wang YY, Liu XG, Kuo SH, Liu N, Song QY, Wang MW. 2016. Cholesterol, 24-hydroxycholesterol, and 27-hydroxycholesterol as surrogate biomarkers in cerebrospinal fluid in mild cognitive impairment and Alzheimer's disease: a meta-analysis. J Alzheimers Dis. 51:45–55.
   PubMed Web of Science ®Google Scholar
• Warner M, Köhler C, Hansson T, Gustafsson JA. 1988. Regional distribution of cytochrome P-450 in the rat brain: spectral quantitation and contribution of P-450b,e, and P-450c,d. J Neurochem. 50:1057–1065.
   PubMed Web of Science ®Google Scholar
• Wassenberg T, Willemsen MA, Geurtz PB, Lammens M, Verrijp K, Wilmer M, Lee WT, Wevers RA, Verbeek MM. 2010. Urinary dopamine in aromatic L-amino acid decarboxylase deficiency: the unsolved paradox. Mol Genet Metab. 101:349–356.
   PubMed Web of Science ®Google Scholar
• Waxman DJ. 1988. Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochem Pharmacol. 37:71–84.
   PubMed Web of Science ®Google Scholar
• Willemsen MA, Verbeek MM, Kamsteeg EJ, de Rijk-van Andel JF, Aeby A, Blau N, Burlina A, Donati MA, Geurtz B, Grattan-Smith PJ, et al. 2010. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain. 133:1810–1822.
   PubMed Web of Science ®Google Scholar
• Willner P. 2017. The chronic mild stress (CMS) model of depression: history, evaluation and usage. Neurobiol Stress. 6:78–93.
   PubMed Web of Science ®Google Scholar
• Wolf U, Rapoport MJ, Schweizer TA. 2009. Evaluating the affective component of the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci. 21:245–253.
   PubMed Web of Science ®Google Scholar
• Yau JL, Noble J, Graham M, Seckl JR. 2006. Central administration of a cytochrome P450-7B product 7alpha-hydroxypregnenolone improves spatial memory retention in cognitively impaired aged rats. J Neurosci. 26:11034–11040.
   PubMed Web of Science ®Google Scholar
• Yue J, Miksys S, Hoffmann E, Tyndale RF. 2008. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course. J Psychiatry Neurosci. 33:54–63.
   PubMed Web of Science ®Google Scholar
• Yu AM, Idle JR, Byrd LG, Krausz KW, Küpfer A, Gonzalez FJ. 2003. Regeneration of serotonin from 5-methoxytryptamine by polymorphic human CYP2D6. Pharmacogenetics. 13:173–181.
   PubMedGoogle Scholar
• Zackrisson AL, Lindblom B, Ahlner J. 2010. High frequency of occurrence of CYP2D6 gene duplication/multiduplication indicating ultrarapid metabolism among suicide cases. Clin Pharmacol Ther. 88:354–359.
   PubMed Web of Science ®Google Scholar
• Zhang F, Li J, Na S, Wu J, Yang Z, Xie X, Wan Y, Li K, Yue J. 2018. The involvement of PPARs in the selective regulation of brain CYP2D by growth hormone. Neuroscience. 379:115–125.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu Q. 2015. Cholesterol metabolism and homeostasis in the brain. Protein Cell. 6:254–264.
   PubMed Web of Science ®Google Scholar
• Zorumski CF, Paul SM, Izumi Y, Covey DF, Mennerick S. 2013. Neurosteroids, stress and depression: potential therapeutic opportunities. Neurosci Biobehav Rev. 37:109–122.
   PubMed Web of Science ®Google Scholar